Get Trend Analysis Icon Get THOR Trend Analysis - it has underperformed the S&P 500 by 24%

Partner Headlines

  1. Industry Themes: Top Stocks Residing In Weak Groups

    Investors Business Daily
  2. Thoratec Announces Approval for HeartMate II in Japan

    Benzinga
  3. UPDATE: Goldman Sachs Upgrades Thoratec Corporation to CL-Buy, ...

    Benzinga
  4. Thoratec Laboratories Corporation (THOR) CEO Gerhard F Burbach ...

    GuruFocus
  5. Stocks Hold Modest Gains; Stratasys Breaks Out

    Investors Business Daily
  6. Thoratec Corp. Reports Operating Results (10-Q)

    GuruFocus
  7. Thoratec Corporation (THOR) VP of Finance, Interim CFO Roxanne ...

    GuruFocus
  8. UPDATE: Oppenheimer Maintains Outperform on Thoratec, $42 PT

    Benzinga
  9. Thoratec Reports Mixed Q2; Abiomed Waits In Wings

    Investors Business Daily
  10. Earnings Scheduled For August 1, 2012

    Benzinga
  11. Thoratec's Pump Keeps Hearts Beating Longer

    Investors Business Daily
  12. Thoratec Corp. (THOR) CEO Gerhard F Burbach sells 37,500 Shares

    GuruFocus
  13. Baxter Tops Q2 Estimates, Guides Q3 Profit Low

    Investors Business Daily
  14. Benzinga's Top Upgrades

    Benzinga
  15. Health Care Sector Wrap

    FOXBusiness
  16. Thoratec Corp. (THOR) CEO Gerhard F Burbach sells 7,222 Shares

    GuruFocus
  17. Top Industries Firing On Only Half Their Cylinders

    Investors Business Daily
  18. Medical Sector Shows Muscle With SXC Health, Cerner

    Investors Business Daily
  19. UPDATE: Oppenheimer Maintains Outperform Rating, Raises PT for ...

    Benzinga
  20. Benzinga's After Hours Earnings Movers

    Benzinga
  21. UPDATE: Goldman Sachs Raises Target to $36 on Thoratec

    at Benzinga
  22. Thor Industries Beats Q2 Estimates

    at Benzinga
  23. Notable Put Options Activity in Thoratec

    at Benzinga
  24. Thoratec Corp. Reports Operating Results (10-K)

    at GuruFocus
  25. UPDATE: Barrington Research Raises Price Target on Thoratec to $38

    at Benzinga
  26. Barrington Research Maintains Thoratec at Outperform, Raises PT ...

    at Benzinga
  27. Rodman & Renshaw Raises Thoratec PT To $42, Maintains Market ...

    at Benzinga
  28. UPDATE: Piper Jaffray Upgrades Thoratec to Overweight

    at Benzinga
  29. Goldman Sachs Maintains Thoratec at Neutral, Raises PT from $33 to $34

    at Benzinga
  30. Piper Jaffray Upgrades Thoratec from Neutral to Overweight, Raises ...

    at Benzinga
  31. UPDATE: Canaccord Lowers Target to $31 on Thoratec

    at Benzinga
  32. Auriga's Thoratec Preparing to Overcome Competitive Hurdle

    at Benzinga
  33. Thoratec

    at IBD
  34. Thoratec Corp Does not Expect FDA Letter will Materially Impact ...

    at Benzinga
People viewing THOR also viewed: , , , , , ,
Marketplace
Trading Center